These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23433574)

  • 1. Polygenic familial hypercholesterolaemia: does it matter?
    Stein EA; Raal FJ
    Lancet; 2013 Apr; 381(9874):1255-7. PubMed ID: 23433574
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study.
    Talmud PJ; Shah S; Whittall R; Futema M; Howard P; Cooper JA; Harrison SC; Li K; Drenos F; Karpe F; Neil HA; Descamps OS; Langenberg C; Lench N; Kivimaki M; Whittaker J; Hingorani AD; Kumari M; Humphries SE
    Lancet; 2013 Apr; 381(9874):1293-301. PubMed ID: 23433573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic screening for familial hypercholesterolaemia in Hong Kong.
    Tan K; Cheung CL; Yeung CY; Siu D; Leung J; Pang HK
    Hong Kong Med J; 2018 Jun; 24 Suppl 3(3):7-10. PubMed ID: 29937437
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic testing for familial hypercholesterolaemia is essential in individuals with high LDL cholesterol: who does it in the world?
    Nordestgaard BG; Benn M
    Eur Heart J; 2017 May; 38(20):1580-1583. PubMed ID: 28419271
    [No Abstract]   [Full Text] [Related]  

  • 5. Familial Hypercholesterolaemia in the Era of Genetic Testing.
    Hughes DP; Viljoen A; Wierzbicki AS
    Curr Cardiol Rep; 2016 May; 18(5):42. PubMed ID: 27002618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
    Haralambos K; Whatley SD; Edwards R; Gingell R; Townsend D; Ashfield-Watt P; Lansberg P; Datta DB; McDowell IF
    Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
    Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
    Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for the diagnosis and management of familial hypercholesterolaemia.
    Sullivan D;
    Heart Lung Circ; 2007 Feb; 16(1):25-7. PubMed ID: 17188936
    [No Abstract]   [Full Text] [Related]  

  • 9. Parental attitude towards genetic testing for familial hypercholesterolaemia in children.
    Umans-Eckenhausen MA; Oort FJ; Ferenschild KC; Defesche JC; Kastelein JJ; de Haes JC
    J Med Genet; 2002 Sep; 39(9):e49. PubMed ID: 12205119
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid testing for three mutations causing familial defective apolipoprotein B100 in 562 patients with familial hypercholesterolaemia.
    Talmud PJ; Tamplin OJ; Heath K; Gaffney D; Day IN; Humphries SE
    Atherosclerosis; 1996 Aug; 125(1):135-7. PubMed ID: 8831935
    [No Abstract]   [Full Text] [Related]  

  • 11. Results from a family and DNA based active identification programme for familial hypercholesterolaemia.
    ten Asbroek AH; de Mheen PJ; Defesche JC; Kastelein JJ; Gunning-Schepers LJ
    J Epidemiol Community Health; 2001 Jul; 55(7):500-2. PubMed ID: 11413180
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality of life in a family based genetic cascade screening programme for familial hypercholesterolaemia: a longitudinal study among participants.
    van Maarle MC; Stouthard ME; Bonsel GJ
    J Med Genet; 2003 Jan; 40(1):e3. PubMed ID: 12525551
    [No Abstract]   [Full Text] [Related]  

  • 13. [Genetic abnormalities effect on LDL metabolism].
    Matsuyama A; Yamashita S
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():534-8. PubMed ID: 11351644
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of Children and Adolescents with Familial Hypercholesterolemia.
    Minicocci I; Pozzessere S; Prisco C; Montali A; di Costanzo A; Martino E; Martino F; Arca M
    J Pediatr; 2017 Apr; 183():100-107.e3. PubMed ID: 28161202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically.
    Wang J; Dron JS; Ban MR; Robinson JF; McIntyre AD; Alazzam M; Zhao PJ; Dilliott AA; Cao H; Huff MW; Rhainds D; Low-Kam C; Dubé MP; Lettre G; Tardif JC; Hegele RA
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2439-2445. PubMed ID: 27765764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetics and screening of familial hypercholesterolaemia.
    Henderson R; O'Kane M; McGilligan V; Watterson S
    J Biomed Sci; 2016 Apr; 23():39. PubMed ID: 27084339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hypercholesterolaemia in a Belgian community.
    Descamps OS
    Acta Cardiol; 2000 Dec; 55(6):327-33. PubMed ID: 11227832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tracing of patients with familial hypercholesterolemia in the Netherlands].
    Umans-Eckenhausen MA; Defesche JC; Scheerder RL; Cliné F; Kastelein JJ
    Ned Tijdschr Geneeskd; 1999 May; 143(22):1157-61. PubMed ID: 10371839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic Diagnosis in Familial Hypercholesterolaemia - no].
    Klose G
    Dtsch Med Wochenschr; 2017 May; 142(9):689-690. PubMed ID: 28454204
    [No Abstract]   [Full Text] [Related]  

  • 20. Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing.
    Knowles JW; Rader DJ; Khoury MJ
    JAMA; 2017 Jul; 318(4):381-382. PubMed ID: 28742895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.